Table 3.

Univariate and Multivariate Analyses of OS and PFS in LAPC Patients

Characteristics	OS						PFS
	Univariate Analysis			Multivariate Analysis			Univariate Analysis			Multivariate Analysis
	HR	95% CI	P	HR	95%	P	HR	95%	P	HR	95%	P
Age	0.517	0.128–1.500	0.225			NI	0.798	0.329–1.936	0.618			NI
Gender	2.005	0.738–5.447	0.172			NI	1.583	0.656–3.822	0.307			NI
Adjuvant chemotherapy	1.036	0.291–3.687	0.957			NI	2.895	0.828–10.126	0.096			NI
Neoadjuvant chemotherapy	0.201	0.061–0.663	0.008	0.368	0.076–0.769	0.012	0.296	0.111–0.783	0.015	0.183	0.055–0.610	0.006
Tumor grade	2.808	0.952–8.282	0.061	2.914	1.921–9.218	0.049	1.418	1.563–3.577	0.049	2.316	1.618–8.679	0.023
Tumor site	1.843	0.676–5.029	0.232			NI	1.799	0.727–4.451	0.204			NI
Tumor size	5.103	1.558–16.716	0.007	6.687	1.692–26.439	0.007	2.557	1.033–6.329	0.042	1.345	1.077–3.794	0.046
LN metastasis	0.974	0.328–2.891	0.963			NI	1.264	0.521–3.068	0.604			NI
Immune panel	3.570	1.015–12.561	0.047	4.073	1.951–17.454	0.039	3.212	1.026–10.053	0.045	4.819	1.225–18.959	0.024

Abbreviations: OS, overall survival; PFS, progression-free survival; NI, not included.